Welcome

The Tumor Vaccine Group at the University of Washington is a multidisciplinary group of investigators focused on the diagnosis, prevention and treatment of cancer with novel, immune-based therapies. Involving scientists, doctors, nurses, and patients, our translational research works to bring the most innovative treatments from the bench to the bedside and to harmonize scientific study with patient care.

We invite you to explore the work we are doing, through scientific research and clinical trials, to further cancer’s diagnosis, treatment, and prevention. This site provides an introduction to immune therapies and our ongoing clinical trials program and pre-clinical research projects.

The Tumor Vaccine Group

The Tumor Vaccine Group
Top Row: Greg Holt, Kathy Tietje, Vivian Goodell, Nora Disis, Jen Childs, Danelle Wallace, Meredith Slota

Middle Row: Molly Boettcher, Hailing Lu, Doreen Higgins, Lupe Salazar, Ekram Gad, Miriam Bolding

Bottom Row: Tess Bayon, Vy Lai, Amy Chang, Yi Yang, Yushe Dang

Not Photographed: Yifeng Zhou, Ron Swensen, Eddy Park, Heidi Gray, Andrew Coveler

Our Mission

  • To conduct basic and clinical cancer research that leads to the development of effective immune-based cancer therapies and diagnostic tests...

  • To foster an environment conducive to high quality research...

  • To teach the next generation of translational researchers...

  • To communicate and share the research that we are conducting with others...

  • And to promote synergy by enlisting the talents and resources of others who share our vision of improving cancer care.
Picture of Our Building
University of Washington South Lake Union campus.